Added to YB: 2025-10-27
Pitch date: 2025-10-23
ROVI.MC [bullish]
Laboratorios Farmaceuticos Rovi, S.A.
-3.94%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
Market Cap
EUR 3.3B
Pitch Price
EUR 64.80
Price Target
N/A
Dividend
1.45%
EV/EBITDA
16.88
P/E
24.87
EV/Sales
4.52
Sector
Pharmaceuticals
Category
value
Laboratorios Rovi (ROVI Spain): Quiet execution turns into strategic credibility
ROVI.MC (quick overview): New Roche manufacturing deal to boost CDMO revenue 25% by 2030, following Bristol Myers expansion. Dual-engine model: growing CDMO + Okedi antipsychotic success. 50% capacity utilization improving with tier-one clients. Trades at discount to Lonza/Catalent peers despite comparable profitability.
Read full article (2 min)